IbisVision has developed ‘Ring of Sight’ (ROS), a unique eye test that is specifically designed for the early detection of glaucoma.
IbisVision has raised $5.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2023.
IbisVision's investors include Scottish Enterprise, Deepbridge Capital, Apollo Informal Investment, Compiler Venture Capital, SBRI Healthcare.
IbisVision is headquartered in Newhouse, United Kingdom.
IbisVision has developed ‘Ring of Sight’ (ROS), a unique eye test that is specifically designed for the early detection of glaucoma.
IbisVision is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IbisVision — Funding & Investors." VCBacked, May 11, 2023, https://www.vcbacked.co/company/ibisvision. Accessed August 17, 2026.
VCBacked. (2023). IbisVision — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/ibisvision
{{cite web |title=IbisVision — Funding & Investors |url=https://www.vcbacked.co/company/ibisvision |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated